Sponsored Links
| Remission Duration Of Lymphoma Doubled By New Therapy |
 |
 |
 |
| Medical News - Hematology | |
|
Clinical research has shown that recurrence of Mantle Cell Lymphoma, a variant of malignant lymphoma, can be reduced by almost 50% in patients who receive maintenance treatment with the antibody rituximab. These results are presented by Dr Hanneke Kluin-Nelemans at the 16th Congress of the European Hematology Association in London... Read more: Blood / Hematology News From Medical News Today
|